INDICATIONS AND USAGE
ALIQOPA is a kinase inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies. Accelerated approval was granted for this indication based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
DOSAGE FORMS & STRENGTHS
For injection: 60 mg as a lyophilized solid in single-dose vial for reconstitution.
Manufactured By: Bayer
Prescribing Information URL: Click Here
FDA approved Anti-Cancer medicine ALIQOPA (copanlisib) for injection is available upon request. To get best retail price of ALIQOPA (copanlisib) for injection in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected]. Medvitaz Pharma Solutions can help you to get access to genuine, affordable and assurance of delivery of approved medicines for Blood Cancer. For advanced treatments in India, Medvitaz can even help patient to discuss with hematologist-oncologist.
Copanlisib (trade name Aliqopa) is a drug which is approved by US FDA for the treatment of adult patients experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies. Copanlisib is an inhibitor of phosphatidylinositol-3-kinase (PI3K) with inhibitory activity predominantly against PI3K-α and PI3K-δ isoforms expressed in malignant B-cells. It has been shown to induce tumor cell death by apoptosis and inhibition of proliferation of primary malignant B cell lines.
You can order copanlisib for injection through Medvitaz Pharma Solutions under Named Patient Program (NPP). Medvitaz provides patients and physicians access to commercially approved medicines that are not available to them in their own country. Medvitaz objectives is to make quality medicines available at affordable prices for patients and physicians. To get best retail price/cost of copanlisib for injection in India, Call 8750295029 or Email [email protected]. FDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.
Head of Operations
The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.
Contact us and we will reply as soon as possible!
MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.
